MSB 3.21% $1.13 mesoblast limited

MSB shareholder class action, page-18

  1. 7,859 Posts.
    lightbulb Created with Sketch. 1350
    Think instos will be eager to buy in at the next cap raise in at most 6 months time?

    As you said, retail barely participated this time.

    In 6 months, when the FDA says no approval until adult trial finishes, so still waiting for results and burning through money, where will the share price be?

    Absolutely not north of where it is now.

    How much dilution will there be to raise the funds at 20c? 15c? What if instos don't see the value even there? This is the issue for MSB - they don't have as money as they wanted, and they're still spending like they've got nothing to lose.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.